SEPT9:

Wenwen Wang1, Xiaochen Zhang2, Ping Gui3

  • 1Translational Medicine Research Center, Key Laboratory of Clinical Cancer Pharmacology and Toxicology Research of Zhejiang Province, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, 310006, Zhejiang, China.

BMC cancer
|September 5, 2024
PubMed
概括

一种关键蛋白质SEPT9,在许多癌症中表达高,与糟糕的结果有关. 向SEPT9对癌症查,预后和免疫治疗有前途,特别是在肺状细胞癌 (LUSC) 中.